NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,784 | -49.8% | 5,368 | -50.3% | 0.17% | -45.6% |
| Q2 2023 | $1,089,727 | -26.3% | 10,799 | -32.9% | 0.31% | -29.0% |
| Q1 2023 | $1,479,544 | +2.6% | 16,082 | +1.1% | 0.44% | -11.6% |
| Q4 2022 | $1,442,539 | +19.4% | 15,901 | 0.0% | 0.49% | +24.2% |
| Q3 2022 | $1,208,000 | -15.0% | 15,901 | -5.4% | 0.40% | -10.6% |
| Q2 2022 | $1,421,000 | +0.1% | 16,813 | +3.9% | 0.44% | +16.0% |
| Q1 2022 | $1,419,000 | -8.8% | 16,176 | -9.1% | 0.38% | +45.2% |
| Q4 2021 | $1,556,000 | +21.7% | 17,790 | +13.7% | 0.26% | +4.4% |
| Q3 2021 | $1,279,000 | -1.1% | 15,651 | +10.4% | 0.25% | -6.3% |
| Q2 2021 | $1,293,000 | +6.9% | 14,180 | +0.1% | 0.27% | -6.3% |
| Q1 2021 | $1,210,000 | -9.5% | 14,163 | 0.0% | 0.29% | -16.3% |
| Q4 2020 | $1,337,000 | +2.4% | 14,163 | -5.7% | 0.34% | -10.0% |
| Q3 2020 | $1,306,000 | +4.0% | 15,025 | +4.4% | 0.38% | +26.2% |
| Q2 2020 | $1,256,000 | – | 14,388 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |